Market by Product, Application, End-user, and Region | Forecast 2021-2028
The detailed analysis of the global digital genome market shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 9.57% during the forecasting years 2021-2028. The usage of digital genomics lies with the genes & their functions and supports in finding reasons behind chronic ailments and resolving them. This technology has flashed a revolt in development-centered research & systems biology to accelerate insight into the most multifaceted genetic systems.
A few years ago, the sequencing
of genomes was limited to the research environment. Now, it is gradually being used
in clinical training, and over the next few years, over 60 million patients’ genomic
data is expected to be generated in the field of healthcare. Millions of genome
sequencing data is available on the genomic databases that are being developed
with the help of government funding too. Thus, due to the continuous funding by
the manufacturers and the government in the field of genomics, the global digital
genome market is expected to witness growth during the forecast period.
The study aims to get
an overview of the digital genome market in terms of various factors. Within
this report, the key insights and the market summary of the digital genome
industry have been discussed. Also, the impact of COVID-19 on the digital
genome market, market attractiveness index, and vendor scorecard have been
studied in detail.
Market drivers like the
proliferating burden of chronic diseases and the continuous funding by the
manufacturers & the government in the field of genomics are driving the digital
genome market growth. However, the industry is facing restraints like security
risks associated with digital genomes and a lack of skilled professionals
pertaining to genome technology, which are obstructing the industry growth.
Key opportunities, like technological advancements and the prevailing awareness in the developing economies regarding DNA sequencing technologies, can be leveraged by the market to reach the anticipated growth.
Geographies
covered in the digital genome market by region are:
• North America: The United States and
Canada
• Europe: The United Kingdom, Germany,
Russia, Spain, Italy, France, and Rest of Europe
• Asia-Pacific: Japan, South Korea,
India, ASEAN countries, China, New Zealand & Australia, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil, and
Rest of Latin America
• Middle East and Africa: Turkey, the
United Arab Emirates, South Africa, Saudi Arabia, and Rest of Middle East &
Africa
The
digital genome market has been segmented as follows:
• By Product:
o Sequencing and Analyzer Instruments
o DNA/RNA Analysis
o Sequencing and Analysis Software
o Sequencing Chips
o Sample Prep Instruments
• By Application:
o Diagnostics
o Drug Discovery
o Academic Research
o Personalized Medicine
o Agricultural
o Other Applications
• By End-user:
o Diagnostics and Forensic Labs
o Academic Research Institutes
o Hospitals
o Other End-users
The key players engaged
in the digital genome market are Bio-Rad Laboratories Inc., Agilent
Technologies Inc., Qiagen NV, Pacific Bioscience, Illumina Inc, Thermofisher
Scientific Inc, F. Hoffmann-La Roche, Inscripta, Oxford Nanopore Technologies
Ltd, Biomerieux SA, Abbott Laboratories, Perkinelmer Inc, Regeneron
Pharmaceuticals, and Becton Dickinson and Company (BD).
The strategic analysis
for each of these corporations has been covered in detail. The company profiles
mentioned in this report help dive into the data about the key market players
in this industry.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
DIGITAL GENOME MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
LANDSCAPE
2.5. KEY
INSIGHTS
2.6. KEY
DRIVERS
2.6.1. PROLIFERATING
BURDEN OF CHRONIC DISEASES
2.6.2. CONTINUOUS
FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY
RESTRAINTS
2.7.1. SECURITY
RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK
OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS
2.8.2. PREVAILING
AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3. DIGITAL
GENOME MARKET OUTLOOK - BY PRODUCT
3.1. SEQUENCING
AND ANALYZER INSTRUMENTS
3.2. DNA/RNA
ANALYSIS
3.3. SEQUENCING
AND ANALYSIS SOFTWARE
3.4. SEQUENCING
CHIPS
3.5. SAMPLE
PREP INSTRUMENTS
4. DIGITAL
GENOME MARKET OUTLOOK - BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG
DISCOVERY
4.3. ACADEMIC
RESEARCH
4.4. PERSONALIZED
MEDICINE
4.5. AGRICULTURAL
4.6. OTHER
APPLICATIONS
5. DIGITAL
GENOME MARKET OUTLOOK - BY END-USER
5.1. DIAGNOSTICS
AND FORENSIC LABS
5.2. ACADEMIC
RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER
END-USERS
6. DIGITAL
GENOME MARKET - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCT
6.1.2. MARKET
BY APPLICATION
6.1.3. MARKET
BY END-USER
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. THE
UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY PRODUCT
6.2.2. MARKET
BY APPLICATION
6.2.3. MARKET
BY END-USER
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. GERMANY
6.2.4.2. FRANCE
6.2.4.3. THE
UNITED KINGDOM
6.2.4.4. ITALY
6.2.4.5. RUSSIA
6.2.4.6. SPAIN
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCT
6.3.2. MARKET
BY APPLICATION
6.3.3. MARKET
BY END-USER
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. AUSTRALIA
& NEW ZEALAND
6.3.4.4. INDIA
6.3.4.5. SOUTH
KOREA
6.3.4.6. ASEAN
COUNTRIES
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCT
6.4.2. MARKET
BY APPLICATION
6.4.3. MARKET
BY END-USER
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. MEXICO
6.4.4.2. BRAZIL
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCT
6.5.2. MARKET
BY APPLICATION
6.5.3. MARKET
BY END-USER
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. SAUDI
ARABIA
6.5.4.2. UNITED
ARAB EMIRATES
6.5.4.3. TURKEY
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPANY
PROFILE
7.1. QIAGEN
NV
7.2. OXFORD
NANOPORE TECHNOLOGIES LTD
7.3. BECTON,
DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA
INC
7.5. THERMO
FISHER SCIENTIFIC INC
7.6. PACIFIC
BIOSCIENCE
7.7. BIO-RAD
LABORATORIES INC
7.8. F.
HOFFMANN-LA ROCHE
7.9. PERKINELMER
INC
7.10. REGENERON
PHARMACEUTICALS
7.11. BIOMERIEUX
SA
7.12. ABBOTT
LABORATORIES
7.13. AGILENT
TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL DIGITAL GENOME MARKET, BY REGION,
2021-2028 (IN $ MILLION)
TABLE 2: VENDOR LANDSCAPE
TABLE 3: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT,
2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL DIGITAL GENOME MARKET, BY REGION,
2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA DIGITAL GENOME MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE DIGITAL GENOME MARKET, BY COUNTRY,
2021-2028 (IN $ MILLION)
TABLE 12: EUROPE DIGITAL GENOME MARKET, BY PRODUCT,
2021-2028 (IN $ MILLION)
TABLE 13: EUROPE DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE DIGITAL GENOME MARKET, BY END-USER,
2021-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC DIGITAL GENOME MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 19: LATIN AMERICA DIGITAL GENOME MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 20: LATIN AMERICA DIGITAL GENOME MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 21: LATIN AMERICA DIGITAL GENOME MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA DIGITAL GENOME MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 23: MIDDLE EAST AND AFRICA DIGITAL GENOME
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: MIDDLE EAST AND AFRICA DIGITAL GENOME
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 25: MIDDLE EAST AND AFRICA DIGITAL GENOME
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA DIGITAL GENOME
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL DIGITAL GENOME MARKET 2021-2028 (IN
$ MILLION)
FIGURE 2: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING
AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 3: GLOBAL DIGITAL GENOME MARKET, BY DNA/RNA
ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING
AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING
CHIPS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL DIGITAL GENOME MARKET, BY SAMPLE
PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL DIGITAL GENOME MARKET, BY
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL DIGITAL GENOME MARKET, BY DRUG
DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC
RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL DIGITAL GENOME MARKET, BY PERSONALIZED
MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL DIGITAL GENOME MARKET, BY AGRICULTURAL,
2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL DIGITAL GENOME MARKET, BY OTHER
APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL DIGITAL GENOME MARKET, BY DIAGNOSTICS
AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC
RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL DIGITAL GENOME MARKET, BY HOSPITALS,
2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL DIGITAL GENOME MARKET, BY OTHER
END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 18: THE UNITED STATES DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 19: CANADA DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 20: EUROPE DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 21: GERMANY DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 22: FRANCE DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 23: THE UNITED KINGDOM DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 24: ITALY DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 25: RUSSIA DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 26: SPAIN DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 27: REST OF EUROPE DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 28: ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 29: CHINA DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 30: JAPAN DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 31: AUSTRALIA & NEW ZEALAND DIGITAL GENOME
MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: INDIA DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 33: SOUTH KOREA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 34: ASEAN COUNTRIES DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 35: REST OF ASIA-PACIFIC DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 36: LATIN AMERICA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 37: MEXICO DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 38: BRAZIL DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 39: REST OF LATIN AMERICA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 40: MIDDLE EAST AND AFRICA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 42: UNITED ARAB EMIRATES DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE 43: TURKEY DIGITAL GENOME MARKET 2021-2028 (IN $
MILLION)
FIGURE 44: SOUTH AFRICA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE 45: REST OF MIDDLE EAST & AFRICA DIGITAL
GENOME MARKET 2021-2028 (IN $ MILLION)